Journal rankings · indicator year 2000
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2000
Infectious Diseases journal rankings 2000
70 ranked journals · Subfield in Medicine
Infectious Diseases has 70 ranked journals in 2000. The median journal has an OJR of 0.60, below the world average of 1.00; Q1 starts at OJR 1.12. The top three are New England Journal of Medicine, Clinical Microbiology Reviews, and Annals of Internal Medicine.
Ranks and citation indicators: 2000. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 1997–1999, the window the 2000 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery316
- Pulmonary and Respiratory Medicine116
- Public Health, Environmental and Occupational Health113
- Cardiology and Cardiovascular Medicine100
- Oncology82
- Epidemiology77
- Infectious Diseases70
- Psychiatry and Mental health65
- Neurology62
- Radiology, Nuclear Medicine and Imaging61
- Physiology59
- Endocrinology, Diabetes and Metabolism48
Show all 42 subfields
- Orthopedics and Sports Medicine45
- Dermatology42
- Pediatrics, Perinatology and Child Health41
- Ophthalmology40
- Hematology37
- Obstetrics and Gynecology31
- Pharmacology22
- Emergency Medicine21
- Nephrology21
- Rheumatology20
- Reproductive Medicine19
- Otorhinolaryngology18
- Rehabilitation15
- Complementary and alternative medicine13
- Geriatrics and Gerontology13
- Critical Care and Intensive Care Medicine11
- Pathology and Forensic Medicine10
- Immunology and Allergy9
- Genetics8
- Anesthesiology and Pain Medicine7
- Hepatology7
- Urology5
- Gastroenterology4
- Internal Medicine3
- Transplantation2
- Family Practice1
- Anatomy0
- Biochemistry0
- Health Informatics0
- Microbiology0
70 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 1999. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 1997–1999, the window the 2000 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 1997–1999 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2000. | Compare |
|---|---|---|---|---|---|---|---|
1New England Journal of MedicineMassachusetts Medical Society · United States | 8.44Q1 | 15.30no 1999 value | 2,603 | 29% | — | — | |
2Clinical Microbiology ReviewsAmerican Society for Microbiology · United States | 7.44Q1 | 14.26no 1999 value | 103 | 60% | — | — | |
3Annals of Internal MedicineAmerican College of Physicians · United States | 2.65Q1 | 5.06no 1999 value | 1,739 | 1% | — | — | |
4AIDSLippincott Williams & Wilkins · United Kingdom | 2.32Q1 | 6.70no 1999 value | 1,113 | 3% | — | — | |
5Emerging infectious diseasesOACenters for Disease Control and Prevention · United States | 2.30Q1 | 4.10no 1999 value | 386 | 100% | — | — | |
6The Journal of Infectious DiseasesOxford University Press · United States | 2.21Q1 | 5.67no 1999 value | 1,866 | 29% | $4,763 | — | |
7Antimicrobial Agents and ChemotherapyOAAmerican Society for Microbiology · United States | 1.80Q1 | 4.29no 1999 value | 1,815 | 99% | — | — | |
8Clinical Infectious DiseasesOxford University Press · United States | 1.79Q1 | 4.14no 1999 value | 1,845 | 25% | $4,763 | — | |
9Journal of Clinical MicrobiologyOAAmerican Society for Microbiology · United States | 1.64Q1 | 3.79no 1999 value | 2,444 | 90% | — | — | |
10AIDS and BehaviorSpringer Science+Business Media · Netherlands | 1.46Q1 | 1.59no 1999 value | 92 | 5% | $4,590 | — | |
11Journal of General VirologyMicrobiology Society · United Kingdom | 1.42Q1 | 3.27no 1999 value | 1,170 | 5% | — | — | |
12Tubercle and Lung DiseaseChurchill Livingstone · United Kingdom | 1.42Q1 | 2.34no 1999 value | 67 | 3% | — | — | |
13Journal of Antimicrobial ChemotherapyOxford University Press · United Kingdom | 1.41Q1 | 2.90no 1999 value | 956 | 19% | $3,784 | — | |
14Epidemiology and InfectionOACambridge University Press · United Kingdom | 1.30Q1 | 2.12no 1999 value | 355 | 99% | $3,550 | — | |
15British Journal of Clinical PharmacologyWiley · United Kingdom | 1.29Q1 | 2.37no 1999 value | 579 | 90% | $4,780 | — | |
16Journal of Medical VirologyWiley · United States | 1.28Q1 | 3.34no 1999 value | 568 | 3% | $4,730 | — | |
17Diagnostic Microbiology and Infectious DiseaseElsevier BV · United States | 1.17Q1 | 2.39no 1999 value | 385 | 1% | $3,290 | — | |
18AIDS Education and PreventionGuilford Press · United States | 1.12Q1 | 1.00no 1999 value | 122 | 2% | — | — | |
19Journal of Medical MicrobiologyMicrobiology Society · United Kingdom | 0.99Q2 | 1.72no 1999 value | 423 | 10% | — | — | |
20AIDS CareTaylor & Francis · United Kingdom | 0.99Q2 | 1.13no 1999 value | 91 | 3% | — | — | |
21Medical Microbiology and ImmunologySpringer Science+Business Media · Germany | 0.92Q2 | 1.88no 1999 value | 81 | 0% | $5,090 | — | |
22American Journal of Infection ControlElsevier BV · United States | 0.90Q2 | 1.99no 1999 value | 257 | 6% | $3,360 | — | |
23Antiviral ResearchElsevier BV · Netherlands | 0.90Q2 | 2.33no 1999 value | 190 | 2% | $4,160 | — | |
24Journal of Hospital InfectionElsevier BV · United Kingdom | 0.89Q2 | 1.94no 1999 value | 449 | 2% | $4,000 | — | |
25Tropical Medicine & International HealthWiley · United Kingdom | 0.84Q2 | 1.41no 1999 value | 366 | 43% | $3,400 | — | |
26Reviews in Medical VirologyWiley · United Kingdom | 0.80Q2 | 1.72no 1999 value | 77 | 8% | $4,880 | — | |
27Infection Control and Hospital EpidemiologyCambridge University Press · United Kingdom | 0.78Q2 | 1.47no 1999 value | 921 | 61% | $3,550 | — | |
28ApmisWiley · United Kingdom | 0.77Q2 | 1.81no 1999 value | 487 | 4% | $4,460 | — | |
29Journal of Investigative MedicineSAGE Publishing · United States | 0.75Q2 | 1.18no 1999 value | 149 | 0% | $3,900 | — | |
30Virus ResearchOAElsevier BV · Netherlands | 0.75Q2 | 1.60no 1999 value | 363 | 6% | $3,010 | — | |
31Scandinavian Journal of Infectious DiseasesInforma · United Kingdom | 0.73Q2 | 1.35no 1999 value | 431 | 0% | — | — | |
32Antiviral TherapyOASAGE Publishing · United Kingdom | 0.68Q2 | 2.03no 1999 value | 67 | 68% | $2,800 | — | |
33Journal of Virological MethodsElsevier BV · Netherlands | 0.66Q2 | 1.58no 1999 value | 519 | 7% | $3,210 | — | |
34AIDS Research and Human RetrovirusesMary Ann Liebert, Inc. · United States | 0.63Q2 | 2.88no 1999 value | 638 | 1% | — | — | |
35InfectionSpringer Science+Business Media · Germany | 0.61Q2 | 1.09no 1999 value | 323 | 4% | $4,790 | — | |
36Journal of InfectionOAElsevier BV · United Kingdom | 0.60Q3 | 1.09no 1999 value | 459 | 1% | $4,030 | — | |
37Clinics in Laboratory MedicineElsevier BV · United States | 0.56Q3 | 0.58no 1999 value | 137 | 12% | $3,000 | — | |
38Microbes and InfectionElsevier BV · France | 0.56Q3 | 1.22no 1999 value | 165 | 99% | $3,510 | — | |
39Medical MycologyOxford University Press · United Kingdom | 0.53Q3 | 0.98no 1999 value | 297 | 20% | $4,889 | — | |
40FEMS Immunology & Medical MicrobiologyOxford University Press · Netherlands | 0.50Q3 | 1.12no 1999 value | 574 | 45% | — | — | |
41International Journal of Infectious DiseasesOAElsevier BV · Netherlands | 0.48Q3 | 1.32no 1999 value | 119 | 100% | $2,900 | — | |
42Viral ImmunologyMary Ann Liebert, Inc. · United States | 0.47Q3 | 1.09no 1999 value | 81 | 7% | — | — | |
43International Journal of STD & AIDSSAGE Publishing · United Kingdom | 0.43Q3 | 0.72no 1999 value | 202 | 2% | $4,150 | — | |
44JAIDS Journal of Acquired Immune Deficiency SyndromesLippincott Williams & Wilkins · United States | 0.42Q3 | 1.28no 1999 value | 184 | 1% | — | — | |
45Clinical Microbiology and InfectionElsevier BV · United Kingdom | 0.41Q3 | 0.81no 1999 value | 553 | 94% | $3,780 | — | |
46Human AntibodiesIOS Press · Netherlands | 0.39Q3 | 0.30no 1999 value | 34 | 0% | $4,150 | — | |
47Reviews in Medical MicrobiologyLippincott Williams & Wilkins · United Kingdom | 0.38Q3 | 1.15no 1999 value | 117 | 0% | — | — | |
48Journal of the Association of Nurses in AIDS CareLippincott Williams & Wilkins · United States | 0.38Q3 | 0.59no 1999 value | 199 | 0% | — | — | |
49AnaerobeElsevier BV · United Kingdom | 0.37Q3 | 0.51no 1999 value | 224 | 2% | $3,350 | — | |
50MycopathologiaSpringer Science+Business Media · Netherlands | 0.36Q3 | 0.47no 1999 value | 284 | 0% | $4,190 | — |
Subfields of Medicine, with Infectious Diseases highlighted.
- Surgery316
- Pulmonary and Respiratory Medicine116
- Public Health, Environmental and Occupational Health113
- Cardiology and Cardiovascular Medicine100
- Oncology82
- Epidemiology77
- Infectious Diseases70
- Psychiatry and Mental health65
- Neurology62
- Radiology, Nuclear Medicine and Imaging61
- Physiology59
- Endocrinology, Diabetes and Metabolism48
- Orthopedics and Sports Medicine45
- Dermatology42
- Pediatrics, Perinatology and Child Health41
- Ophthalmology40
- Hematology37
- Obstetrics and Gynecology31
- Pharmacology22
- Emergency Medicine21
- Nephrology21
- Rheumatology20
- Reproductive Medicine19
- Otorhinolaryngology18
- Rehabilitation15
- Complementary and alternative medicine13
- Geriatrics and Gerontology13
- Critical Care and Intensive Care Medicine11
- Pathology and Forensic Medicine10
- Immunology and Allergy9
- Genetics8
- Anesthesiology and Pain Medicine7
- Hepatology7
- Urology5
- Gastroenterology4
- Internal Medicine3
- Transplantation2
- Family Practice1
- Anatomy0
- Biochemistry0
- Health Informatics0
- Microbiology0
Journals
Citations made in 2000. Corpus-wide, 66.2% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
29 additional Infectious Diseases journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 1997–1999, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2000. Publication window: 1997–1999. How these summaries are calculated
- Ranked journals
- 70
- Window papers (baseline)
- 18,375 Change unavailable from indicator year 1997
- Median OJR
- 0.602 Change unavailable from indicator year 1997
- Rising journals (2025)
- 48
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 1997–1999 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 70 | 73 | 78 | 82 | 86 | 92 | 95 | 101 | 106 | 110 | 118 | 131 | 144 | 162 | 173 | 182 | 189 | 198 | 210 | 217 | 222 | 234 | 243 | 259 | 263 | 258 | |
| Window papers (baseline) | 18,375 | 21,167 | 22,805 | 24,640 | 25,208 | 28,008 | 31,333 | 35,063 | 38,170 | 42,272 | 46,364 | 49,515 | 52,080 | 54,445 | 58,513 | 62,728 | 67,259 | 69,548 | 70,742 | 70,658 | 72,743 | 100,768 | 135,954 | 162,915 | 153,103 | 130,899 | |
| Median OJR | 0.602 | 0.68 | 0.82 | 0.76 | 0.77 | 0.901 | 0.98 | 0.93 | 1.04 | 0.998 | 1.01 | 0.999 | 0.97 | 0.900 | 0.91 | 0.874 | 0.85 | 0.8699 | 0.8696 | 0.83 | 0.80 | 0.597 | 0.61 | 0.64 | 0.70 | 0.75 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.